# Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/intercalated-combination-of-chemotherapy-and-erlotinib-for-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yi‐Long Wu,Jin Soo Lee,Sumitra Thongprasert,Chong‐Jen Yu,Li Zhang,Guia Ladrera,Vichien Srimuninnimit,Virote Sriuranpong,Jennifer Sandoval-Tan,Yunzhong Zhu,Meilin Liao,Caicun Zhou,Hongming Pan,Victor Lee,Yuh-Min Chen,Yan Sun,Benjamin Margono,Fatima Fuerte,Gee‐Chen Chang,Kasan Seetalarom,Jie Wang,A C K Cheng,Elisna Syahruddin,Xiaoping Qian,Jcm Ho,Johan Kurnianda,Hsingjin Eugene Liu,Kate Jin,Matt Truman,Ilze Bāra,Tony Mok |
| Citations | 304 |
| DOI | 10.1016/s1470-2045(13)70254-7 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2124967121 |
| PMID | 23782814 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)
- [Chong‐Jen Yu](https://scholariq.org/researchers/chong-jen-yu/)
- [Jcm Ho](https://scholariq.org/researchers/jcm-ho/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.